Table 3.
Hazard ratio (95% confidence intervals) of Type 2 Diabetes for the higher biomarker level as stated, by sex and meta-analyzed across countries.
| Sex | Biomarker | Model | HR (95% CI) | p value | Heterogeneity I2 (%) | 
|---|---|---|---|---|---|
| Men | |||||
| Ferritin (per 100 μg/L ) | 1 | 1.18 (1.12; 1.25) | <0.001 | ||
| 2 | 1.13 (1.08; 1.19) | <0.001 | |||
| 3 | 1.06 (1.01; 1.12) | 0.021 | 72.20 | ||
| TSAT≥45% | 1 | 0.99 (0.81; 1.20) | 0.885 | ||
| 2 | 1.06 (0.86; 1.32) | 0.579 | |||
| 3 | 0.90 (0.75; 1.08) | 0.259 | 0.0 | ||
| Serum Iron (per 5 μmol/L) | 1 | 1.03 (0.98; 1.08) | 0.293 | ||
| 2 | 1.04 (0.98; 1.11) | 0.166 | |||
| 3 | 1.00 (0.94; 1.07) | 0.976 | 49.40 | ||
| Transferrin (per 0.5 g/L) | 1 | 1.20 (1.12; 1.30) | <0.001 | ||
| 2 | 1.16 (1.05; 1.29) | 0.003 | |||
| 3 | 1.11 (1.00; 1.23) | 0.061 | 54.50 | ||
| Women | |||||
| Ferritin (per 100 μg/L) | 1 | 1.31 (1.22; 1.41) | <0.001 | ||
| 2 | 1.22 (1.14; 1.31) | <0.001 | |||
| 3 | 1.12 (1.05; 1.19) | 0.001 | 53.50 | ||
| TSAT≥45% | 1 | 0.54 (0.44; 0.67) | <0.001 | ||
| 2 | 0.73 (0.59; 0.91) | 0.004 | |||
| 3 | 0.68 (0.54; 0.86) | 0.002 | 0.0 | ||
| Serum Iron (per 5 μmol/L) | 1 | 0.92 (0.89; 0.95) | <0.001 | ||
| 2 | 1.02 (0.97; 1.07) | 0.403 | |||
| 3 | 1.00 (0.95; 1.05) | 0.869 | 38.00 | ||
| Transferrin (per 0.5 g/L) | 1 | 1.30 (1.21; 1.41) | <0.001 | ||
| 2 | 1.24 (1.15; 1.34) | <0.001 | |||
| 3 | 1.22 (1.12; 1.33) | <0.001 | 55.30 | ||
| Men and Women | |||||
| Ferritin (upper vs. lower quintile)† | 1* | 2.46 (2.05; 2.96) | <0.001 | ||
| 2* | 1.77 (1.57; 2.00) | <0.001 | |||
| 3* | 1.36 (1.20; 1.54) | <0.001 | 5.3 | ||
Model 1: age and center adjusted
Model 2: further adjustment for BMI, physical activity, smoking status and level of education
Model 3: further adjustment for hsCRP, ALT and GGT
additional adjustment for sex
Ferritin quintile cut-points:
Men (μg/L): ≤68, >68-117, >117-177, >177-270, >270
Women (μg/L): ≤24, >24-45, >45-73, >73-121, >121